Solomon B Margolin
Deceased
from Dallas, TX
- Also known as:
-
- Solomon Dr Margolin
- Solomon Nancy Margolin
- Solomon B Cox
- Solomon B Margoun
- Begelfor Margolin Solomon
- Soloman B Cox
- O Margolin Solomon
- Phone and address:
-
6723 Desco Dr, Dallas, TX 75225
2143619870
Solomon Margolin Phones & Addresses
- 6723 Desco Dr, Dallas, TX 75225 • 2143619870
- Ewing, NJ
- Paterson, NJ
- Montclair, NJ
- Stockton, NJ
Us Patents
-
Compositions And Methods For Treatment Of Epilepsy
view source -
US Patent:6956044, Oct 18, 2005
-
Filed:Feb 21, 2000
-
Appl. No.:10/204605
-
Inventors:Solomon B. Margolin - Dallas TX, US
-
International Classification:A01N043/40
-
US Classification:514315, 514327
-
Abstract:A method of treating a mammal with an epileptic condition, comprising: administering to said mammal a pharmaceutical composition containing an effective amount of an N-phenyl substituted 2-pyridone compound and/or pharmaceutically acceptable salts thereof.
-
Methods For Treatment Of Benign And Malignant Tumors, Including Lymphomas, Leukemias, And Leiomyomas
view source -
US Patent:RE40155, Mar 18, 2008
-
Filed:Nov 27, 2000
-
Appl. No.:09/724378
-
Inventors:Solomon B Margolin - Dallas TX, US
-
International Classification:A61K 31/47
-
US Classification:514313, 514334, 514336
-
Abstract:In a preferred embodiment, drugs having chemotherapeutic properties which are useful against certain neoplastic disorders with wide safety margins as evidenced by their low toxicity, and molecular actions. Such drugs include as active ingredient(s) one or more N-substituted 2-(1H) pyridone(s) and/or N-substituted 3-(1H) pyridone(s). The compositions of this invention are novel as anti-neoplastic drugs, namely as an agent for treating leukemias, lymphomas, and leiomyomas as agent().
-
Treatment Of Sepsis With 5-Ethyl-1-Phenyl-2(1H)-Pyridone
view source -
US Patent:8093210, Jan 10, 2012
-
Filed:Mar 9, 2009
-
Appl. No.:12/921107
-
Inventors:Solomon B. Margolin - Dallas TX, US
Shri N. Giri - Addison TX, US -
Assignee:Solanan, Inc. - Dallas TX
-
International Classification:A61K 38/00
A61K 31/445
C07D 211/72 -
US Classification:514 14, 514345, 424643, 546290
-
Abstract:A pharmaceutical composition comprising 5-ethyl-1-phenyl-2-(1H)-pyridone (5-EPP) and its use for the treatment of sepsis are disclosed.
-
Compositions And Methods For Reparation And Prevention Of Fibrotic Lesions
view source -
US Patent:57166323, Feb 10, 1998
-
Filed:May 9, 1996
-
Appl. No.:8/647006
-
Inventors:Solomon B. Margolin - Dallas TX
-
International Classification:A61K 902
A61K 914
A61K 920
A61K 948 -
US Classification:424423
-
Abstract:In a preferred embodiment, drugs having pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as active ingredient(s) one or more N-substituted 2-(1H) pyridone(s) and/or N-substituted 3-(1H) pyridones. The composition of this invention is novel as an anti-fibrotic drug, namely, as an agent for treating fibrosis. Any existing compounds have not been shown to be effective for the reparation and prevention of fibrotic lesions.
-
Compositions And Method For Treatment Of Lymphomas, Leukemias, And Leiomyomas
view source -
US Patent:61143537, Sep 5, 2000
-
Filed:Jan 28, 1999
-
Appl. No.:9/239211
-
Inventors:Solomon B. Margolin - Dallas TX
-
International Classification:A61K 3144
A61K 3147 -
US Classification:514313
-
Abstract:In a preferred embodiment, drugs having chemotherapeutic properties which are useful against certain neoplastic disorders with wide safety margins as evidenced by their low toxicity, and molecular actions. Such drugs include as active ingredient(s) one or more N-substituted 2-(1H) pyridone(s) and/or N-substituted 3-(1H) pyridone(s). The compositions of this invention are novel as anti-neoplastic drugs, namely as an agent for treating leukemias, lymphomas, and leiomyomas.
-
Compositions And Methods For Reparation And Prevention Of Fibrotic Lesions
view source -
US Patent:55187293, May 21, 1996
-
Filed:May 16, 1994
-
Appl. No.:8/243058
-
Inventors:Solomon B. Margolin - Dallas TX
-
International Classification:A61K 902
A61K 914
A61K 920
A61K 948 -
US Classification:424423
-
Abstract:In a preferred embodiment, drugs having pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as the active ingredient one or more N-substituted 2-(1H) pyridone(s). The composition of this invention is novel as an anti-fibrotic drug, namely, as an agent for treating fibrosis. Any existing compounds have not been shown to be effective for the reparation and prevention of fibrotic lesions.
-
Composition And Method For Reparation And Prevention Of Fibrotic Lesions
view source -
US Patent:53105621, May 10, 1994
-
Filed:Sep 21, 1992
-
Appl. No.:7/947995
-
Inventors:Solomon B. Margolin - Dallas TX
-
International Classification:A61K 902
A61K 914
A61K 920
A61K 948 -
US Classification:424489
-
Abstract:In a preferred embodiment, drugs having heretofore unknown pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as the active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone. The pharmaceutical composition of this invention is novel as an anti-fibrotic drug, namely, as an agent for treating fibrosis. Any existing compounds have not been shown to be effective for the reparation and prevention of fibrotic lesions.
-
Inhibition Of Tumor Necrosis Factor .Alpha.
view source -
US Patent:59624787, Oct 5, 1999
-
Filed:Mar 19, 1998
-
Appl. No.:9/044441
-
Inventors:Solomon B. Margolin - Dallas TX
-
International Classification:A61K 3144
-
US Classification:514345
-
Abstract:In a preferred embodiment, a method for the inhibition of the synthesis and release of tumor necrosis factor from various cells, comprising: administering to a human or other mammal an effective dose of one or more pharmaceutical substances selected from the group consisting of N-substituted 2(1H)pyridones, N-substituted 3(1H)pyridones, and pharmaceutically acceptable salts thereof.
Name / Title
Company / Classification
Phones & Addresses
President
MARNAC, INC
Mfg Pharmaceutical Preparations · Pharmaceutical Preparations
Mfg Pharmaceutical Preparations · Pharmaceutical Preparations
9010 Jamaica Bch, Galveston, TX 77554
9400 N Central Expy, Dallas, TX 75231
2146928544
9400 N Central Expy, Dallas, TX 75231
2146928544
President, Director
CYMAR, INC
1905 Linford Dr, Allen, TX 75013
11034 Shady Trl, Dallas, TX 75229
11034 Shady Trl, Dallas, TX 75229
President, Director
SOLANAN, INC
Business Services at Non-Commercial Site
Business Services at Non-Commercial Site
1905 Linford Dr, Allen, TX 75013
11034 Shady Trl, Dallas, TX 75229
11034 Shady Trl, Dallas, TX 75229
Manager
MARGOLINCOX GP, LLC
1905 Linford Dr, Allen, TX 75013
11034 Shady Trl, Dallas, TX 75229
11034 Shady Trl, Dallas, TX 75229
Youtube
Get Report for Solomon B Margolin from Dallas, TXDeceased